The author Ramin Tadayoni reports grants and is consultant for Novartis, AbbVie Allergan, and Bayer; is consultant for Alcon, Genentech, Roche, Thea, KHB, Apellis, Iveric Bio, and Oculis; his department has received non-financial support from Zeiss and has had Nidek machines for long term test periods. All other authors have no relevant financial or non-financial interests to disclose.